• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>St. Jude Medical

St. Jude Medical

St Jude Medical Inc STJ

Last Price$81.70Day Change (%)0.17%
Open Price$81.40Day Change ($)0.14
Day Range81.38–81.8552-Week Range48.83–81.86

As of Fri 7/22/2016 5:44:00 PM | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Abbott Results, Helped by Product Launches, Top Views

    Abbott Results, Helped by Product Launches, Top Views

  2. EU5 Interventional Cardiology Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Abbott Labs, Medtronic, Cordis Corp - Research and Markets

    EU5 Interventional Cardiology Market Report 2016-2021 - Analysis, Technologies & Forecasts - Key Vendors: Abbott Labs, Medtronic, Cordis Corp - Research and Markets

  3. Global LVAD Market 2016-2020 - Shortage of Heart Donors / Availability of Alternative Treatments / Increase in M&A - Research and Markets

    Global LVAD Market 2016-2020 - Shortage of Heart Donors / Availability of Alternative Treatments / Increase in M&A - Research and Markets

  4. NightBalance Closes EUR 12.5 Million Series B Financing to Support Commercial Rollout in Europe and Enter the U.S. Market with Its Innovative Sleep Apnea Device

    NightBalance Closes EUR 12.5 Million Series B Financing to Support Commercial Rollout in Europe and Enter the U.S. Market with Its Innovative Sleep Apnea Device

  5. Medtronic to Buy HeartWare for $1.1 Billion

    Medtronic to Buy HeartWare for $1.1 Billion

  6. US Heart Defect Closure Devices Market - 2016 (Forecasted to 2022) - MedCore - Research and Markets

    US Heart Defect Closure Devices Market - 2016 (Forecasted to 2022) - MedCore - Research and Markets

  7. US Cardiac Assist Devices Market - 2016-2022- MedCore - Research and Markets

    US Cardiac Assist Devices Market - 2016-2022- MedCore - Research and Markets

  8. US Market for Heart Valve Devices - 2016 (Forecasted to 2022) - MedCore - Research and Markets

    US Market for Heart Valve Devices - 2016 (Forecasted to 2022) - MedCore - Research and Markets

  9. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

  10. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.